Yüklüyor......
Pazopanib and Statin-Induced Rhabdomyolysis
BACKGROUND: The VEGF inhibitor pazopanib is a widely used first-line therapy for the treatment of advanced renal cell carcinoma. Potential drug-drug interactions and toxicities may be underrecognized. CASE PRESENTATION: A 73-year-old woman with metastatic renal cell carcinoma on treatment with pazop...
Kaydedildi:
| Yayımlandı: | Case Rep Oncol |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
S. Karger AG
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5731169/ https://ncbi.nlm.nih.gov/pubmed/29279698 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000481659 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|